entertainment -WSS

entertainment

author：comprehensive 2025-09-30 14:09:46 - browse：92

Adobe

Some of the country’s biggest health insurers said Tuesday that up to one-quarter of their claims are run through Change Healthcare, UnitedHealth Group’s technology company that sustained a massive cyberattack two weeks ago.

Speaking at investor conferences, executives from Humana, Elevance Health, and CVS Health, which owns Aetna, said the biggest impact they’re seeing is fewer bills coming in from providers. For insurers, that means less visibility into how much they’ll have to pay for their members’ medical care in the beginning of the year, although they noted that providers and pharmacies have adopted workarounds that are helping the situation.

“This past weekend we saw a significant increase in activity levels relative to recent years, which suggests in large part that providers are catching up their submissions,” Mark Kaye, Elevance’s chief financial officer, said at TD Cowen’s annual health care conference. Elevance was previously Anthem.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： It costs an awful lot of money to give away a kidney

explore

WSS

The cancer stories no one wants to hear

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Alabama frozen embryo ruling has major implications for IVF clinics

How I helped Pfizer think through the ethics of Viagra

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

FDA scientists endorse Pfizer/BioNTech Covid

focus

entertainment

leisure time

Drug repurposing or repositioning? The language matters

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Hollywood unions extend contract negotiations for actors

Why palliative psychiatry is worth discussing

Medical records are filled with copy

A solution to the after

What does generative AI mean for health care? We asked experts

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Dobbs anniversary: the lost opportunity of abortion as health care

Group behind ProMed defends move to subscription

focus

Physicians aren't 'burning out.' They're suffering from moral injury

6 phony surgeries that take placebo to the extreme

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Antivenom research: Lessons from HIV applied in search for universal antidote

FDA scientists endorse Pfizer/BioNTech Covid

NIH study of ME/CFS points to clear biological hallmarks

entertainment

leisure time

explore

hotspot